Go from drug discovery to drugstore faster with spray drying
Perhaps ironically, developing medicines has always been a rather painful business. Unearthing new compounds, isolating APIs, formulating therapies, conducting clinical trials, gaining approval, securing patents, winning doctors’ confidence - it all takes a lot of time, money and energy. Of course the rewards, financial and personal, make it well worthwhile.
Yet despite all efforts, the chances of ending up with a blockbuster in your hands remain incredibly slim - and declining. R & D productivity is under real pressure while investment is at record highs. The challenge in recent years has not only been finding new compounds, but formulating known discoveries into commercial products.
Many potential treatments sit stranded between basic research and prescription medicine due to issues such as insolubility, instability and delivery system. What’s more, this trend is gathering momentum as companies explore new routes to drug discovery, such as biotechnology research.
Spray drying is a breakthrough technology that offers R & D staff a unique remedy to some of the formulation challenges facing the modern pharmaceutical business.
Specifically the unprecedented particle control achievable with spray drying opens the way to employing previously unattainable delivery methods and molecular characteristics.
These advantages not only remove many of the obstacles to turning new discoveries into commercial drugs, but can also provide new avenues forlife-cycle management and patent extension.
Widely used in the chemical and food industries, spray drying has been adapted to meet the exacting standards of the healthcare sector by Niro. The world’s leading supplier of pharmaceutical spray dryers, Niro has spent more than a decade refining its technology specifically for use within the area of final solid dosage drug forms.
<--- CLICK TO DOWNLOAD